We report a case of cefepime neurotoxicity characterised by myoclonic status epilepticus with coma, in a context of acute renal failure and requiring one discontinuous conventional haemodialysis. Cefepime is a fourth-generation broad-spectrum cephalosporin mainly used to treat hospital-acquired Gram-negative infections. Acute neurotoxicity is an increasingly reported adverse effect which occurs predominantly in patients with renal impairment. Renal replacement therapy has been proposed to treat this condition.
Keywords: dialysis; epilepsy and seizures; healthcare improvement and patient safety; unwanted effects/adverse reactions.
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.